INNOVENT BIOLOGICS INC financial statements, including revenue, expenses, profit, and loss

The total revenue of 1801 for the last semiannual is 4.28 B HKD, and it's 13.12% higher compared to the previous semiannual. The net income of H1 24 is -425.45 M HKD.